Delivery Order SPE2DR25D3404-SPE2DR26F5X8B
Award Date 3/9/26
Potential Completion Date 3/30/26
Potential Value $77K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $128,188.50 firm fixed-price delivery order to Amerisourcebergen Drug Corp on March 3, 2026, for Ocrevus 300 mg/10 mL vials. The order is placed against the DLA Troop Support Medical IDC, a $999,999,999 indefinite delivery contract running through December 2026 that supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. Ultimate completion date is March 24, 2026.
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 10, 2026, for Ocrevus 300 mg/10 ml vial 10 ml, with a ceiling value of $76,913.10. Place of performance is Conshohocken, PA. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (SPE2DX), a global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026, which enables supply of a comprehensive range of pharmaceutical products and medical supplies...
- The Defense Logistics Agency issued a $62,536.68 delivery order to Amerisourcebergen Drug Corp on March 9, 2026, for Ocrevus 300 mg/10 mL vials under a firm fixed-price arrangement. The order's ultimate completion date is March 30, 2026. Place of performance is Conshohocken, Pennsylvania. The delivery order was issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, which supports pharmaceutical supply across military healthcare systems globally. Amerisourcebergen...
- <p>The Defense Logistics Agency issued a $51,493.52 delivery order to Amerisourcebergen Drug Corp on February 24, 2026, for OCREVUS 300 mg/10 mL vials.</p> <p>The order is placed against Amerisourcebergen's Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. Place of performance is Conshohocken, PA. The ultimate completion date is March 17, 2026. Pricing is firm fixed price with no set-aside applied.</p>
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 26, 2026, for Ocrevus 300 mg/10 mL vials with a ceiling value of $76,913.10.</p> <p>Place of performance is Conshohocken, PA. The order has an ultimate completion date of March 19, 2026, and is priced on a firm fixed-price basis.</p>
- <p>The Defense Logistics Agency issued a $38,456.55 delivery order to Amerisourcebergen Drug Corp on February 27, 2026, for Ocrevus 300 mg/10 mL vial (10 mL) under a firm fixed-price contract. Ultimate completion date is March 20, 2026. Place of performance is Conshohocken, PA.</p>
- <p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 26, 2026, with a ceiling value of $76,913.10 for OCREVUS 300 mg/10 mL vials.</p> <p>The order is issued under the DLA Troop Support Medical IDC held by parent company Cencora, Inc., valued at up to $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA. The order carries an ultimate completion date of March 19, 2026 and is priced on a firm fixed-price basis.</p>
- The Defense Logistics Agency awarded a $136,567.97 delivery order to AmerisourceBergen Drug Corp for the supply of Ocrevus (ocrelizumab) 300 mg/10 mL vials on April 24, 2025, with completion expected by May 15, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be...
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 10, 2026, for $76,913.10 under a parent Indefinite Delivery Contract with the DLA Troop Support Medical (SPE2DX) for Ocrevus 300 mg/10 mL vials.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of March 4, 2026. No set-aside was used.</p>
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $63,332.40 to AmerisourceBergen Drug Corp for the supply of Ocrevus 300 mg/10 ml vials on November 28, 2025. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 19, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. Ocrevus is a specialized pharmaceutical product used in the treatment of multiple sclerosis and represents part of the...